Training Hematology and Oncology Fellows in Clinical Research

培训血液学和肿瘤学研究员进行临床研究

• 批准号: 10188469
• 负责人: Ramiro Garzon
• 金额: $ 17.32万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10188469
• 关键词: Clinical Research; Hematology; Oncology; Training

PROJECT SUMMARY The objective of this Ohio State University postdoctoral clinical T32 training program entitled: “Training Hematology and Oncology Fellows in Clinical Research” is to provide a state of the art clinical research training experience, specifically for postdoctoral fellows in Hematology and Oncology with an M.D., D.O., or equivalent degree who have demonstrated a firm commitment to patient oriented cancer research. The overriding goal of this training program is to prepare Hematology and Oncology fellows in the OSU Divisions of Hematology and Medical Oncology for academic careers in patient oriented clinical and translational cancer investigation. Progress in cancer therapy and prevention requires strong collaborative efforts, and patient oriented physician investigators provide a critical link with physician-scientists and basic scientists toward this goal. The recent explosive growth of scientific discoveries and the increasing complexity of cancer clinical trials, particularly phase I/II studies of novel therapeutic agents and regimens, make it imperative that trainees in Hematology/Oncology acquire the proper training through appropriate mentoring, to prepare them for careers in clinical and translational investigation. This T32 program will prepare fellowship trainees for productive academic careers by providing an intellectually rigorous curriculum, strong mentoring and support from senior faculty, protected time for academic training during fellowship, “hands on” experience in developing and writing clinical studies and research papers, and ample opportunities to enhance their OSU experience with extramural programs and workshops sponsored by the NCI or other professional academic organizations such as ASCO and ASH. The participating members consist of the 2 Program Directors, Coordinating Committee members, Advisory Committee members, primary mentors, and contributing faculty, who were chosen based on their prior track record of successful mentoring and their demonstrated commitment to clinical and translational research. T32 fellows will commit for two years of training. The strengths of the OSUCCC, primarily in the fields of cancer prevention and experimental therapeutics, is the perfect environment to our planned success. Our T32 proposal is designed to foster and ensure the development of fellowship trainees, who we will train to assume academic clinical research positions as faculty members upon graduation. The T32 program is engineered to empower trainees to become independent clinical and translational investigators. Trainees will have mandatory an elective training in various settings, including the opportunity to obtain one or two master degrees; they will be required to create an investigator initiated clinical study and will start its implementation during training; they will be required to apply for funding for their own study through peer reviewed grant mechanisms; and they will be offered the opportunity to network nationally with the NCI and oncology professional organizations. OSUCCC is also deeply committed to training women and members of underrepresented racial and ethnic groups for academic careers as shown in continuous efforts to recruit and train female and underrepresented minority fellows.

项目摘要 这个俄亥俄州州立大学博士后临床T32培训项目的目标是：“培训 临床研究血液学和肿瘤学研究员”提供最先进的临床研究培训 经验，特别是血液学和肿瘤学博士后研究员与医学博士，国防部，或同等 学位谁已经表现出坚定的承诺，以病人为导向的癌症研究。的首要目标 该培训计划旨在培养OSU血液学分部的血液学和肿瘤学研究员， 医学肿瘤学在以患者为导向的临床和转化癌症研究的学术生涯。 癌症治疗和预防的进展需要强有力的合作努力， 研究人员为实现这一目标提供了与医学科学家和基础科学家的关键联系。近期 科学发现的爆炸性增长和癌症临床试验的日益复杂，特别是阶段 新的治疗药物和方案的I/II研究，使得血液学/肿瘤学的受训者必须 通过适当的指导获得适当的培训，为他们的临床和翻译职业做好准备 调查这个T32计划将通过提供一个有效的学术生涯准备奖学金学员， 智力严谨的课程，强大的指导和支持，从高级教师，保护时间的学术 在奖学金期间接受培训，在开发和撰写临床研究和研究论文方面有“动手”经验， 和充足的机会，以提高他们的OSU的经验与校外计划和研讨会赞助 由NCI或其他专业学术组织，如ASCO和ASH。与会成员 包括2个项目主任，协调委员会成员，咨询委员会成员，主要 导师和有贡献的教师，他们是根据他们之前成功指导的记录而选择的 以及他们对临床和转化研究的承诺。T32研究员将承诺两年 训练。OSUCCC的优势，主要是在癌症预防和实验领域， 治疗学，是我们计划成功的完美环境。我们的T32提案旨在促进和 确保奖学金学员的发展，我们将培训他们担任学术临床研究职位 作为教职员工T32计划旨在使学员能够成为 独立的临床和翻译研究者。学员将有各种强制性的选修培训 设置，包括获得一个或两个硕士学位的机会;他们将被要求创建一个 研究者发起临床研究，并将在培训期间开始实施;他们将被要求申请 通过同行评审的资助机制为自己的研究提供资金;他们将有机会 与NCI和肿瘤学专业组织建立全国网络。OSUCCC也致力于 培训妇女和代表性不足的种族和族裔群体的成员从事学术事业， 继续努力征聘和培训女性和代表性不足的少数群体研究员。